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Lymphoid and myeloid cells represent distinct lineages of a common hemato-
poieticstem cell (1-3) . This distinction is dramatically illustrated in the autosomal
recessive mouse mutant, scid . t Micehomozygous for the scid mutation (scid mice)
are severely deficient in B and T lymphocytes whereas other hematopoietic cell
types such as erythrocytes, monocytes, granulocytes, and megakaryocytes (all
members of the myeloid series) are present in normal number (4, 5) . Although
the scid mutation appears to affect only lymphocyte development (4-10), it is
not yet clear what stage of lymphoid differentiation is impaired or arrested .
Recent results suggest that the effects of the scid mutation become manifest
after the commitment of lymphoid cells to the B andT cell pathways . First, early
transcription of unrearranged H chain and TCR loci, which presumably signals
the opening of these loci to factors responsible for gene recombination (11-16),
is detectable in scid fetal liver and thymus, respectively (Schuler,W., A. Schuler,
andM. J. Bosma, unpublished results) . Second, although cells with H chain (or
TCR) gene rearrangements cannot be directly demonstrated in freshly harvested
lymphoid tissues of adult scid mice (17), early B cell lines with H chain gene
rearrangements can be recovered from Abelson murine leukemia virus-trans-
formed scid bone marrow cells (17) and from long-term cultures of scid bone
marrow cells (18) . There is also indication of earlyT cell development as thymic
lymphomas with rearranged TCR-'Y and TCR-# alleles spontaneously appear in
^-15% of scid mice (5, 17, 19) . It is striking, however, that the majority of
rearranged H chain and TCR alleles in transformed scid lymphocytes show
abnormal J region deletions . The deletions remove allJ-coding exons ofa given
J region and appear to result from attempted D toJ or V toJjoining ; they vary
in size and extend both 5' and 3' of the deletedJ regions (17, 19). Evidence of
abnormal J-associated deletions has also been reported for rearranged H chain
alleles of long-term B cell lines derived from scid bone marrow cells (18) .
To explain the abnormal J-associated deletions and how they might account
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' Abbreviations used in this paper:
￿
scid, severe combined immune deficiency ; SPF, specific patho-
gen-free .
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for the scid phenotype, we recently proposed the following (17) . The scid
mutation causes highly error-prone Ig and TCR gene rearrangements; conse-
quently, most developing scid lymphocytes lack an antigen receptor due to
nonproductive rearrangements at both alleles of a critical antigen receptor locus
(e.g ., H chain) . The apparent absence of these nonfunctional cells in scid lymph-
oid tissues may result from their rapid turnover (elimination) . On the other
hand, developing scid lymphocytes that by chance make two productive re-
arrangements at the appropriate Ig or TCR loci would survive and express an
antigen receptor . Antigen-dependent clonal expansion of one or more of these
relatively rare cells could account for our earlier observation (4) that some scid
mice (^-15%) appear leaky in that they produce detectable serum Ig .
Leaky scid mice are important to understanding the nature of the scid defect
and are the subject of this report . They will be referred to as scid(Ig') mice . As
shown here, most scid(Ig') mice contain only a few clones of 1g-producing B
cells; they also appear to contain a limited number of functional T cells. The
regulation of these relatively few lymphocytes may be minimal as many scid(Ig')
mice have abnormally high concentrations of serum Ig and/or develop T cell
lymphomas. Clearly, scid(Ig') mice are not normal, and possible explanations for
their appearance are discussed .
Materials and Methods
Mice. The scid mutation occurred in an H chain congenic partner strain of
BALB/cAnIcr known as C.B-17 (4). C.B-17 mice that are homozygous for the scid
mutation are here designated as scid mice ; heterozygotes are designated as scid/+ mice .
All scid and scid/+ mice as well as the normal mice (C.B-17 [H-2d], C3H/HeJ [H-2k],
and [C.B-17 X C3H/HeJ]F,) used in these studies were derived from specific pathogen-
free (SPF) breeder stocks of the ICR animal facility (SPF mice have a defined flora and
are free of all known mouse pathogens) . The SPF breeder stocks were maintained behind
a barrier in rooms with HEPA-filtered air and were housed in microisolator cages (Lab
Products Inc., Maywood, NJ)containing sterilized foodandwater . Progenyof thebreeder
stocks were transferred into a conventional animal room at 3-4 wk old and were
maintained thereafter as "non-SPF" mice in microisolator cages containing sterilized food
and water; mice were transferred to clean sterile cages within a class II type safety cabinet
(Bellco Glass, Inc., Vineland, NJ). Non-SPF mice were used exclusively in all experiments
except where noted .
Ig Quantitation .
￿
An ELISA (20) was used to quantitate serum Ig-a concentrations .
This was done in the manner previously describedfor acompetitive RIA (21, 22) . Briefly,
mictotiter wells (Dynatek Laboratories, Inc., Alexandria, VA) were first coated with
purified myelomaK chains ofMOPC-46B (23) and then with rabbit antisera to IgG2a Fab
fragments of the MOPC-173 myeloma protein (23) . The reference antigen was the IgGI-
K myeloma protein of MOPC-31c (23) which was conjugated with alkaline phosphatase
(Sigma Chemical Co ., St . Louis, MO) by glutaraldehyde cross-linking (24) . The relative
amount ofbound enzyme conjugate in each well wasascertained by addition of paranitro-
phenyl phosphate (Sigma Chemical Co.) . The extent of paranitrophenyl phosphate hy-
drolysis was measured at 405 run in an MR 580 Micro-Elisa Auto-Reader (Dynatek
Laboratories, Inc.) . Serum Ig-a concentrations were calculated from the standard curve.
Ig Isotypes .
￿
Serum samples were assayed for the presence of the major Ig isotypes
(IgM, IgG3, IgGI, IgG2b, IgG2a, and IgA) by double diffusion analysis in micro-
Ouchterlony plates . Affinity-purified goat (and rabbit) antisera specific for the above
mouse Ig isotypes were obtained from Litton Bionetics(Charleston, SC) .
IEF of L Chains.
￿
Ig from normal BALB/c and C.B-17 sera, scid(Ig') sera or from
myeloma ascites was isolated by absorption onto protein A-Sepharose (Pharmacia Canada1018
￿
LEAKY scid MICE
Ltd. Dorval, Quebec) followed by elution in 8 M urea, 0.05 M Tris-HCI, pH 8 .0. The
eluted material was precipitated with methanol and redissolved in 8 M urea, 0.05 M Tris-
HCI buffer for reduction and alkylation. Reduction and alkylation with ["C]iodoacetamide
(Amersham Corp., Arlington Heights, IL) was carried out in a two-step procedure as
described (25). H and L chains were separated by PAGE at pH 3 .0 in the presence of 8
M urea. After electrophoresis, the light chain zone was cut from the gel and transferred
to the surface of an IEF gel containing 2% carrier ampholines (LKB Instruments, Inc.,
Gaithersburg, MD, pH 3-10) and 6.6 M urea. IEF, fixing, and drying of the gel have
been described (25). The autoradiograms represent 3-6-d exposures.
Western Blot Analysis.
￿
Cell lysates of lymph node, spleen, and bone marrow were
prepared, reduced, and subjected to electrophoresis in 10% polyacrylamide gels as
previously described (26). Prestained molecular weight standards (Bethesda Research
Laboratories, Gaithersburg, MD) were applied to all gels. The contents of the gel were
electroblotted onto nitrocellulose after which the nitrocellulose blot was overlaid sequen-
tially with goat anti-IgM (Litton Bionetics) and "5I-IgM of MOPC-104E. After autoradi-
ographs of the blot were made, the process was repeated with goat anti-IgG-a (Litton
Bionetics) and "5I-IgGI-a of MOPC-31c. Proteins were radiolabeled with"I (Amersham
Corp.) using the chloramine T method of Hunter (27). Details of the above Western blot
procedure are described elsewhere (26).
FACS Analysis.
￿
Aliquots ofspleen cells (106 cells) from scid, scid/+, and C.B-17 normal
mice were incubated with antibodies specific for various lymphocyte surface antigens. The
antibodies included FITC-conjugated rabbit anti-mouse IgM (Litton Bionetics), FITC-
conjugated (Fab')2 fragment of goat anti-mouse IgG (Fab')2 specific antibody (Cappel
Laboratories, West Chester, PA), rat monoclonal anti-Ly5(B220) (28), FITC-conjugated
rat monoclonal (30-H12) anti-Thy-1 (29), rat monoclonal anti-mouse Ly-1 (29), and
FITC-conjugated rabbit anti-rat Ig (from R. L. Coffman, DNAX, CA) as a second-stage
reagent. The incubations, washings, and counterstaining with ethidium bromide to exlude
dead cells were carried out as previously described (4, 5). Cells were analyzed on a FACS
II (Becton Dickinson & Co., Mountain View, CA).
Mitogen Stimulation. scid, scid/+, and CB-17 normal spleen cells were depleted of
erythrocytes by Tris-ammonium chloride lysis and plated at 5 X 105 cells/well (96-well
plates, Costar, Data Packaging Corp., Cambridge, MA) in RPMI-1640 medium supple-
mentedwith 10% FCS, 2 X 10-'M2-ME, 10 mM Hepes, and 2 mM L.-glutamine. Medium
was also supplemented with Con A (5 jig/ml; Sigma Chemical Co.) or with bacterial LPS
(5 Ag/ml; Difco Laboratories, Inc., Detroit, MI). Cultures were incubated at 37°C in a
humidified atmosphere of 5% C02 for 48 h after which 1 uCi [5H]thymidine (New
England Nuclear, Boston, MA) was added to each well . After an additional 18-h incuba-
tion, cells were harvested using a MASH filter harvester and assayed for [5H]thymidine
incorporation by ,8-scintillation counting.
Skin Grafts. The grafting of full-thickness skin grafts was done according to the
procedure of Billingham and Silvers (30). scid mice were grafted on one flank with
allogenic skin of (C.B-17 X C3H/Hej)F, or C3H/HeJ mice and with a control graft (from
scid or C.B-17 normal mice) on the other flank. Grafts were covered with a small telfa
sterile pad (Curity; Colgate-Palmolive Co., New York, NY) and held in place with I-in
clear First Aid Tape (Johnson and Johnson, New Brunswick, NJ) wrapped around the
thorax. The bandage was removed 10 d later and grafts were checked closely for possible
rejection over the next several weeks.
Histologic Preparations. Tissues were fixed in Carson's 10% neutral formol (31),
embedded in methacrylate glycol (JB-4; Polysciences, Inc., Warrington, PA), and sectioned
at 2 tLm on a Sorvall JB-4 microtome (DuPont Instruments, Newtown, CT). They were
stained routinely with hematoxylin and eosin.w
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FIGURE 1 .
￿
Histogram ofSerum Ig-K concentrations in non-
SPF scid mice. All mice were 3-4 mo old.
TABLE I
Frequency ofscid(Ig+)Mice as a Function ofAge andEnvironment
* Select groups of very old mice (>12 mo old) that were also tested at 3-4 and
7-9 mo old.
Serologic Analysis ofscid(Ig+) Mice
Results
Frequency.
￿
Routine serological testing of 3-4-mo-old scid mice revealed cir-
culating Ig in ^"15% of the mice . As illustrated in Fig. 1, 78 of 545 mice analyzed
had serum Ig-K concentrations ranging from 0.10 to >6.4 mg/ml; the remaining
467 mice (scid[Ig] mice) lacked detectable Ig-rc (<0.01 mg/ml). Mice with >0.05
mg/ml of serum Ig-IC are designated as scid(Ig+) mice.
The chance of a given scid mouse becoming Ig' appeared to be influenced by
both its environment and age. As shown in Table 1, <_5% of 3-9-mo-old SPF
mice typed Ig'. However, when SPF mice were removed from their barrier
environment at 3-4 wk old and subsequently maintained as non-SPF mice in a
conventional animal facility for 2-8 mo, the percentage of Ig+ mice went up to
Number ofmice
Age
mo
Tested Ig+
19+
3-4 222 12 5.4
3-4 40 1 2.5
8-9 40 2 5.0
14-15 40 13 32.5
3 486 66 13.6
4 263 48 18.2
5 217 50 23.0
3-4 76 9 11.8
7-8 76 14 18.4
12-14 76 36 47.4
Group Environment
A SPF
B*
C Non-SPF
D
E
F*1020
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FIGURE 2 . Serum Ig-K concentrations in
individual scid(Ig+), scid/+, andC.B-17 nor-
mal mice (+/+) . Each point represents an
individual mouse at the respective ages. The
same scid(Ig+) mice were tested at 3-4 and
7-8 mo old .
13-23% . In the non-SPF environment, the proportion of Ig+ mice appeared to
increase slightly from 3 to 9 mo old. At 12 mo and older, the percentage of
individuals with detectable Ig increased dramatically to 32% in SPF mice and to
46% in non-SPF mice . However, the levels of Ig in many of these very old Ig+
mice were low (<0 .2 mg/ml), unlike those of 3-8-mo-old scid(Ig+) mice (see Fig .
2) . All subsequent analyses pertain to mice 3-9 mo old.
It is important to note here that the scid(Ig+) phenotype is not inherited . This
is clear from pedigree analyses of scid(Ig+) and scid(Ig) mice . Also, we have not
been able to increase the frequency of scid(Ig+) mice by selective breeding .
Variable Ig Levels.
￿
Fig. 2 emphasizes the enormous variation in Ig-K concen-
trations between individual scid(lg+) mice . The values for 3-4-mo-old scid(Ig+)
mice were widely scattered (from 0.1 to >10.0 mg/ml), in striking contrast to
the tightly clustered values of age-matched scid/+ and C.B-17 normal homozy-
gotes (+/+) . When the same scid(lg+) mice were again tested at 7-8 mo old, all
but one mouse showed higher levels of Ig-u . The mean Ig-K concentration ± the
standard deviation at 7-8 mo old was 4.49± 4.53 mg/ml vs . 1 .59± 2.04 mg/ml
at 3-4mo old.
It is of interest to note that the mean Ig-K concentration in 3-4-mo-old scid/+
mice (1 .3 ± 0.3 mg/ml) was significantly less than that of age-matched C.B-17
normal mice (3 .0 ± 0.72 mg/ml) . Also, at 7-9 mo old, ^-25% of tested scid/+
mice (5/18) retained relatively low levels of Ig-K ; the remaining mice showed
Ig-K levels (^-4.0 mg/ml) comparable to those of age-matched C.B-17 normal
mice . These differences may reflect a slower development of functional lympho-
cytes in scid/+ heterozygotes than inC.B-17 normal mice .
Representation of Ig Isotypes .
￿
Table II indicates the different distribution
patterns ofH chain isotypes that were observed in 48 scid(lg+) mice . 8% of the
mice (group A) were positive for all H chain isotypes tested (1,, y3, y1, -y2b, y2a,
and a), 40% lacked only a (group B), 27% lacked a and y2a (group C), 15%
lacked a and one or more 7 isotypes (y l, y2b, y2a) (group D), and 10% lackedBOSMA ET AL .
￿
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TABLE II
Representation ofH Chain Isotypes in scid(Ig+ ) Mice
* The presence or absence of agiven isotype is scored with + or -; mice
in groups D and E lacked one or two of the y isotypes enclosed by the
brackets .
FIGURE 3 . Illustration
￿
of
very restricted (pauciclonal)
IEFpatterns ofserumLchains
in scid(Ig') mice . Each mouse
(7141, 5494, 7171, 6221)was
sampled twice ; the interval (in
weeks) between each bleed is
indicated in parentheses . L
chains of normal BALB/c (C)
and C.B-17 (C.B) serum and
of purified myeloma proteins
(MP) were included as con-
trols . The first lane contained
L chains from three myeloma
proteins : PC-4050 (IgG2b-Vx-
21B); PC-7644 (IgG3-K); and
PC-8643 (IgGI-x) . The last
lane contained the Lchains of
HOPC-I (IgG2a-al) . The pH
across the gel wasdetermined
at l0°C using a surface elec-
trode (Ingold, Urdorf, Swit-
zerland) .
both,uand a and one or more y isotypes (y I, y2b, y2a) (group E) . Most scid(Ig')
mice (>_85%) lacked detectable A light chains (data not shown) .
Restricted Heterogeneity ofL Chains.
￿
IEF of L chains in serum of 3-9-mo-old
scid(Ig') mice gave very restricted IEF patterns . Forty-one scid(Ig') mice were
examined . All of these mice had distinct and restricted IEF patterns unlike the
complex and indistinguishable patterns of individual C.B-17 normal mice . Rep-
resentative results are shown in Figs. 3 and 4. Most scid(Ig') mice, as illustrated
in Fig . 3, showed only 4-10 major bands corresponding to 1-3 clones of Ig-
Group Mice
w y3
Distribution
ofH chain
yI
patterns
isotypes*
y2b y2a a
n%
A 4(8) + + + + + +
B 19(40) + + + + + -
C 13(27) + + + + - -
D 7(15) + + [ 1 -
E 5(10) - + [ ] -1022
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FIGURE 4 .
￿
Illustration of re-
stricted IEF patterns ofserum
L chains in scid(Ig') mice .
Each mouse (5422, 6401,
4716, 4988) was sampled
twice ; the interval (in weeks)
between each bleed is indi-
cated in parentheses. L chains
of normal BALB/c (C) and
C.13-17 (C.B)serumandof pu-
rified myeloma proteins (MP)
were included as controls .The
first lane contained L chains
from three myeloma proteins:
FLOPC-1 (IgGI-VKAA) ; PC-
7477 (IgG3-Vrc-21E) ; and PC-
1229 (IgG2b-Va-21A) . The
last lane contained the L
chains of HOPC-1 (IgG2a-A1) .
ThepH across the gel was de-
termined at 10°C usinga sur-
face electrode (Ingold) .
producing cells asjudged from the number of L chain bands obtained with one
(last lane) or a mixture of three myeloma proteins (first lane) . Othermiceshowed
more complex IEF patterns consisting of>10 bands (e.g., 6401, 4988 in Fig . 4) .
Some scid(Ig') mice displayed the same IEF pattern for many weeks (e.g., 7141
in Fig . 3 and 5422 in Fig . 4) . In other mice the pattern changed with time ; i .e .,
new bands appeared along with retention of old bands (e.g., 4716 in Fig . 4) . In
some cases, there was a clear loss of certain bands (e.g., 4988 in Fig . 4) .
Western Blot Analysis ofSpleen and Bone Marrow Cell Lysates.
￿
Spleen and bone
marrow cell lysates of scid(Ig') mice were subjected to electrophoresis in 10%
polyacrylamide containing 0.1 % SDS ; the contents of each gel were electroblot-
ted onto nitrocellulose and the blots were sequentially coated with 0.5% casein,
anti-A, 1251-IgM, and exposed to X-ray film for 3 and 16 h . The same was done
for spleen, lymph node, and bone marrow cells of C.B-17 normal mice . The
blots were later sequentially coated with anti-y/K-specific sera and 1251-IgG-a as
described below . Using this procedure, the spleen lysates of 12 scid(Ig') mice
were analyzed and found to contain y and K chains; 9 of these lysates also
contained detectable ,u chains . Representative results are shown in Fig . 5 . No A
chains were detected in the bone marrow lysates of scid(Ig') mice and neither A,,
y, nor K chains were found in spleen lysates of scid(Ig) mice (data not shown) .
As illustrated in Fig . 5a, the apparent molecular mass of the k chains in the
spleen lysate of scid(Ig') mice (lane 4) was equivalent to the smaller of two
distinct molecular masses ofA . chain (80 kD and 76 kD) found in the spleen lysateBOSMA ET AL .
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FIGURE 5 .
￿
Western blot of reduced cell lysates (subjected to electrophoresis in 10% poly-
acrylamide gels containing 0.1% SDS) of lymph node (1), spleen (2), and bone marrow (3),
from aC.B-17 normal mouse vs . spleen (4) ofa scid(Ig') mouse . The blot was first sequentially
overlaid with affinity-purified anti-mouse IgM and "5I-IgM to reveal' chains as shown in
autoradiograph; (a and b) 3- and 16-h exposure . A second sequential overlay of affinity-
purified anti-mouse IgG-Kand ...I-IgG-a revealed ic-specific bands of ^-25 kD (lanes 1-4) and
a 56-kD band in lane 4 that presumably corresponds to y chains . This is shown in (c) 16-h
exposure.The positions ofthe molecular mass standards (92, 68, 43, and 25 kD) are indicated
between each autoradiograph,
of C.B-17 normal mice (lane 2) . Interestingly, the 80-kD 1 chains predominated
in C.B-17 lymph node cells (lane 1) while the 76-kD u chains predominated in
C.B-17 bone marrow cells (lane 3) . This striking disproportion in the distribution
of the 80-kD and 76-kD u chains was regularly observed and whether it reflects
tissue-specific differences in the proportion (or glycosylation) of membrane
and/or secreted forms of u chains is not clear . What is clear, however, is that
the ,u.-containing cells in the spleen of scid(Ig') mice appeared to resemble those
found in normal bone marrow .
Longer exposure of the blot in Fig. 5a revealed additional bands correspond-
ing to a molecular mass of -53 kD and ^"57 kD (see Fig. 5b) . These bands
represent truncated u chains and were described in an earlier report (26) .
A second sequential coating of the blot shown in Fig. 5a and b, with anti-y/K
specific antisera and 1251-IgG-K revealed a prominent 56-kD band in the scid(Ig')
spleen lysate (Fig . 5 c, lane 4) . This putative y-specific band was not apparent
after the first sequential coating with anti-/ (see Fig. 5 b, lane 4) and it clearly
distinguished scid(Ig') mice from C.B-17 normal mice as it was not detected in
the control spleen lysate (compare lane 2 in Fig . 5b and c) . Consistent with
expectation, bands corresponding in size to L chains (25-27 kD) appeared in all
lanes of Fig . 5 c . These results suggest that an abnormally high quantity of IgG
is being produced (or concentrated) in the spleen of scid(Ig') mice .
Attempted Clonal Expansion of Ig-producing Scid Cells and Apparent Absence of
Functional B Cell Precursors in Bone Marrow. Attempts to expand Ig-producing
cell clones of scid(Ig') mice involved the following kind of cell transfer experi-
ments . Splenic cells of individual scid(Ig') mice were injected intravenously into1024
￿
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scid(Ig) recipients; i.e., the equivalent of one donor spleen was equally divided
and transferred into two recipients. Seven of nine such experiments failed to
result in detectable Ig in the recipients. However, in two experiments, Ig
production was seen in both pairs of recipients beginning at 3-4 wk after cell
transfer, Ig-a levels (1-2 mg/ml) remained relatively constant over the next 6-8
wk and then declined to <0.1 mg/ml at 16-18 wk after cell transfer.
In another series of experiments, 5-10 X 106 bone marrow cells of scid(Ig+)
mice were injected intravenously into x-irradiated BALB/c mice. We found that
bone marrow cells of six individually tested mice were unable to generate
detectable IgG-producing cells of donor allotype. Control recipients, which were
injected with as few as 2 X 105 bone marrow cells of C.B-17 normal mice,
expressed donor IgG allotype within 3-4 wk after cell transfer.
Cellular Analysis ofscid(Ig+) Mice
Histopathology. scid(Ig+) mice retained the same fundamental histologic ab-
normalities described previously for scid(Ig) mice (4, 5). The notable difference
in scid(Ig+) mice was the finding of irregularly scattered foci of lymphocytes
differentiating to plasmacytes. Plasmacytic foci were detected in 27 of 50 scid(I')
mice examined. The foci (illustrated in Fig. 6) were found solely in the spleen of
9 mice, in one or more lymph nodes of 6 mice, and in nodes and spleen of 10
mice. One mouse contained plasmacytic foci in thymus and spleen, and another
in thymus, spleen, and lymph nodes. Most splenic and thymic areas of plasma-
cytosis were small, the major ones being nodal. In all foci, there was an intermin-
gling of lymphocytes, intermediate plasmacytoid lymphocytes, and classic plas-
macytes. In six cases, the plasmacytic cytoplasm contained Russell bodies (intra-
cellular inclusions of Ig) (32-34).
Lympho-plasmacytic activity was not found in ~50% of the necropsied scid(Ig+)
mice. This is not surprising, in that our search was limited to a few thin sections
of assorted lymphatic tissues and many foci were small and unevenly distributed.
It is important, however, to note that no plasmacytic focus was found in the
many scid(Ig) mice examined.
FACS Analysis.
￿
Splenic cells of scid(Ig+) mice appeared markedly deficient in
the expression of common lymphocyte antigens. For example, cells expressing
surface 1 chains were not detected and few (<5%), if any, Ly-l + or Ly-5(8220)+
cells were found (see Table III). Seven scid(Ig+) mice were tested for the presence
of Ly-5(8220), a pre-B and B cell marker present on 37-49% of the control
splenic cells. All seven mice lacked detectable Ly-5(B220) even though three of
the mice, numbered 5507, 4988, and 4976, had 11, 16, and 66% of their splenic
cells stain positive for Ig, respectively. These Ig+ cells presumably corresponded
to a population of Ly-5(8220)- plasmacytes (28).
Mitogen Responsiveness.
￿
Splenic cells of scid (Ig+) mice were as unresponsive
to lymphocyte mitogens as splenic cells of scid(Ig) mice. This is shown in Fig. 7
for the B and T cell mitogens, LPS and Con A, respectively. In 16 scid(Ig+) mice
tested, the LPS stimulation index was <_3.0 as opposed to 30-60 for normal C.B-
17 control mice (data not shown). The same scid(Ig+) mice were also tested for
Con A responsiveness. In 14 mice the Con A stimulation index was <_3 .0; the
stimulation indices in the remaining 2 mice were 4.9 and 6.0 . In contrast, controlBOSMA ET AL.
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FIGURE 6.
￿
Cervical lymph nodes of scid(Ig+) mouseshowing multifocal sites of lymphocytes
differentiating to plasmacytes with Russell bodies . (A) Two seemingly concentric or abutting
areas (m), pallid by virtue of degenerating background cells and macrophage influx, each
margined by a darker zone of lymphocytes (1) which blend with plasmacytes (p) that solidly
occupy the remainder of the node (X 63). (B) Area of 1 in A distinguishes the three zones
mentioned above . (X 252) . (C) Area 1' in A shows degenerated center on the right, with
nuclear debris engulfed by macrophages (m), with lymphocytes (1) in the center, and piasma-
cytoid lymphocytes (p)on the left (X 630). (D)Similar situation at the uppermargin of B, with
gradation from lymphocytes (1) to plasmacytoid lymphocytes (p) above . A macrophage (m)
with engulfed cellular debris is seen in the lower left (X 630) . (E) A second lymph node with
changes similar to those noted in A. Nodes elsewhere were too small to harvest, and thymus
and spleen were sparsely populated with lymphocytes, being similar to scid(Ig) mice (X 63).
(F) Field from upper right of E, showing further maturation of plasmacytes with acquisition
of Russell bodies (R) (X 1,250).
splenic cells ofC.B-17 normal mice gave ConA stimulation indices ranging from
150 to 280 (data not shown) . Splenic cells from six additional scid(Ig+) mice
(denoted with an x) gave comparable Con A stimulation indices expecting one
mouse with an index of 21 .0 . LPS and Con A stimulation indices for scid(Ig)1026
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TABLE III
Expression ofLymphocyte Surface Antigens on Splenic Cells ofscid(Ig+) and Control Mice
FIGURE 7. Proliferative response of spleen cells
from individual scid(Ig) and scid(Ig') mice to Con A
and LPS . The stimulation index is the ratio of ['H]-
thymidine incorporation obtained withCon A or LPS
to that obtained in medium alone . All values represent
a single mouse . In most cases, each mouse was ana-
lyzed for both Con A and LPS responsiveness ; some
mice (x) were tested only for Con A responsiveness .
The stimulation indices of control spleen cells (from
C.B-17 normal mice) ranged from 150 to 280 in the
case of Con A and from 30 to 60 in the case of LPS
(data not shown) .
mice were also generally negative (<_2 .0). A few scid(Ig) mice (<15%) showed
indices ranging from 4.0 to 15 .0 .
AllograftRejection .
￿
Although the preceding mitogen analyses failed to indicate
the presence of functional T cells in the spleen of scid(Ig') mice, such cells
apparentlydidarise in scid(Ig+) mice . As shown in Table IV, many scid(Ig') mice
were able to reject allogeneic skin grafts . 14 scid(Ig') and 34 scid(Ig) mice were
grafted on one flank with full-thickness allogeneic skin grafts from (C.B-17 x
C3H/Hej)F,, or C3H/HeJ mice and on the other flank with syngeneic (control)
grafts from scid(Ig) or C.B-17 normal mice . 7 ofthe 14 scid(Ig''') mice completely
rejected their allogeneic grafts in 12-33 d ; the mouse that took 33 d rejected a
second allogeneic graft in 12 d . 3 of the 14 mice appeared to reject part of their
allogeneic graft; i.e ., necrosis was observed in the middle of the graft and yet the
Mouse
genotype
Mouse
number
Serum
K
Cell surface markers (%
IgG(Fab) B220
positive
Thy-1
cells)
Lyl
mg/ml
C.B-17scid 3875 <0.01 4 11
3874 5.1 10 15
3879 4.7 9 13
4037 5.6 <1 10
4016 <0.01 <1 20
3427 <0.01 <1
4976 6.5 66 <1
4988 2.5 16 <1
5209 <0.01 <1 <1
5494 7.5 <1 2 2 2
5407 5.0 3 3 4 5
5498 6.5 <1 2 <1 3 6
5507 10.6 <1 11 4 22 9
C.B-17scid/+ 2973 1 .8 44 37
2987 2.1 51 41
3011 1 .6 45 31
C.B-17(+/+) 2763 3.2 49 39 49 46 36
2954 3.5 52 55 43 37 37TABLE IV
Survival ofAllogenic Skin Grafts on scid(Ig-) vs. scid(Ig+) Mice
Number
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Number of mice with grafts
* C.B-17scid mice were each grafted with skin of C.B-17 or C.B-17scid mice (control grafts) on one
flank andon theother flankwith skin of (C.B-17 X C3H/HeJ) F1 (exp. 1 and 3) or C3H/HeJ mice
(exp. 2 and 4). The mice in experiments 1 and 3 were grafted and maintained within a barrier
facility as SPF mice.
$The mean time for allograft rejection by normal C.B-17 mice was 14 ± 3 d. oThis mouse rejected a second graft in 12 d.
remaining portion of the graft persisted and grew hair. We denote this as
incomplete rejection (see Table IV) rather than technical failure since this kind
ofresult was not observed for any of the control syngeneic grafts. In contrast to
scid(Ig') mice, only 1 of 34 grafted scid(Ig) mice completely rejected its alloge-
neic graft and only 1 showed evidence of incomplete rejection. The possibility
that these two mice became Ig'' during the course of the experiment cannot be
excluded because they unfortunately were not retested. Since alloreactive anti-
bodies could not be demonstrated in theserumofscid(Ig') mice (data notshown)
and since the rejection of allogeneic skin grafts is a T cell-dependent process
(35), the above data indicate that most scid(Ig') mice contain functional Tcells.
T Cell Lymphomas.
￿
Unlike their normal counterpart, scid mice are prone to
develop lymphomas (4). Spontaneous lymphomas have been detected in ^-15%
ofnecropsied mice, they appear to arise in the thymus, and all examined to date
type as Tcell lymphomas (reference 5 and our unpublished results). As indicated
in Table V, a disproportionate number of these lymphomas occur in scid(Ig')
mice. 13 of 41 necropsied scid(Ig') mice (32%) were found to contain thymic
lymphomas as opposed to 9 of 109 mice (8.3%). Both groups of mice ranged
from 3 to 5 mo old. In an older group of scid(Ig') mice, more than half of the
mice (10/17) had thymic lymphomas.
Discussion
Elapsed time
Evidence for Pauciclonal Ig-producing B Cells in scid(Ig+) Mice.
￿
As deduced
from the preceeding results, most 3-9-mo-old scid(Ig') mice appeared to contain
^"1-3 clones of Ig-producing B cells. IEF of serum L chains from individual
Exp. Recipients* grafted Accepted Partially
rejected
Completely
rejected
forcomplete
rejection*
d
scid (Ig-)
1 8 8
2 7 7
3 14 12 1 1 12
4 _5 _5 _ _
Total 34 32 1 1
scid (Ig+)
1 1 1 39
2 3 1 2 13,22
3 5 1 1 3 12, 14, 14
4 _5 _2 _2 _1 17
Total 14 4 3 71028
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TABLE V
Incidence of Thymic Lymphoma in scid(Ig-)and scid(Ig+)Mice
scid(Ig') mice showed very restricted IEF patterns which, in most cases, consisted
of 4-10 bands. Equally restricted IEF patterns were obtained with L chains of
1-3 different myeloma proteins. Each scid(Ig') mouse gave a distinct IEF pattern
suggesting considerable diversity of B cell clones in the scid(Ig') mouse popula-
tion. In most individuals, a given IEF pattern persisted throughout the period of
observation (2-5 mo) with little or no change. Thus, the appearance of new B
cell clones was apparently minimal .
Recent analysis ofsplenic hybridomas from two scid(Ig') mice has also indicated
a paucity of Ig-producing B cell clones (36). 16 Ig-producing hybridomas were
obtained from 1 mouse, 2 of which produced IgM and 14 of which produced
IgG2b. Sequence analysis of the IgM-producing hybridomas along with 2 ran-
domly picked IgG2b-producing hybridomas showed that all used Vh3609, Jh2,
and a common D region. All 18 Ig-producing hybridomas obtained from another
mouse produced IgG2b. Sequence analysis of two such hybridomas showed that
both expressed the same Ig heavy chain variable region (Vh7183, Jh4, and
DQ52) in addition to sharing common mutations. Apparently, the spleen in each
of the above two mice contained only a single clone of Ig-producing plasmacytes.
Interestingly, proliferating B cell clones were not evident in the spleens of some
scid(Ig') mice as no Ig-producing hybridomas were obtained (Solvason N., M.
Fried, M . J. Bosma, and J. F. Kearney, unpublished results). This implies that
the tissue distribution of Ig-producing plasmacytes is uneven and limited to a
few lymphatic sites.
Our histologic findings support the above inference. Plasmacytic foci-con-
sisting of lymphocytes, intermediate plasmacytoid lymphocytes, classic plasma-
cytes and, in some cases, plasmacytes with Russell bodies-were found in 27 of
50 scid(Ig') mice examined. Usually, the foci were detected in only one or two
lymphoid tissues of a given mouse. For example, in five mice where several
lymph nodes were available for study, one or more nodes showed robust plas-
macytosis while others were dissimilar, displaying lymphocytic depletion or
hyperplasia without plasmacytic differentiation or early lymphomatous change.
Even within a tissue, such as the spleen, foci were distributed irregularly; i .e .,
foci were detected in some but not all follicles or were sparsely scattered in the
perifollicular red pulp. We interpret the restricted and patchy tissue distribution
of plasmacytic foci as a reflection of multiple "hit and miss" cloning of a limited
number of cell progeny from one or more lymphoid ancestor cells.
Ig class switching by individual B cell clones was not impaired as multiple
Mouse
phenotype
Age
range
mo
Number
Necropsied
of mice
With lym-
phoma
Lymphoma
incidence
scid(Ig) 3-5 105 9 8.2
scid(Ig') 3-5 41 13 31 .7
scid(Ig') 5-9 17 10 58.8BOSMA ET AL.
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isotypes were detected in >_90% of scid(Ig') mice. Most mice, however, lacked
two or more of the six major serum Ig classes (IgM, IgG3, IgGI, IgG2b, IgG2a,
and IgA); those classes most often absent corresponded to the most downstream
H chain constant region genes (i.e., IgG2a and IgA) (37). Total Ig-K concentra-
tions in scid(Ig') mice ranged from 0.1 to >10 .0 mg/ml. Ig-a concentrations in
a given mouse generally increased with time and often approached those found
in plasmacytoma-bearing C.B-17 mice (our unpublished results). However, nei-
ther plasmacytomas nor any other kind of B cell malignancy have been detected
in scid(Ig') mice. Therefore, we seem to be dealing with unregulated Ig produc-
tion by a few "normal" B cell clones. Naturally occurring antigens may play an
important role in the activation and clonal expansion of these B cell clones,
because the appearance of scid(Ig') mice was environmentally dependent (see
Table I). Preliminary results indicate that some B cell clones may be autoreactive.
For example, hybridoma antibodies reactive to nuclear antigens were obtained
from one of the two scid(Ig') mice cited earlier (36). Also, anti-DNA antibodies
have been detected in the serum of many scid(Ig') mice (A. D. Steinberg and M.
J. Bosma, unpublished results).
Finally, the association of plasmacytosis and Russell body formation with
hypergammaglobulinemia and autoreactive Ig deserves comment as this associ-
ation also has been observed in various lymphoproliferative disorders and hyper-
immune states. For example, plasmacytes with intracellular inclusions of Ig
(Russell bodies) have been observed in myeloma patients (32), in germinal centers
ofpatients with AIDS (38), in chronic inflammatory lesions (33), in hyperimmune
animals (39), and in mice with lymphoproliferative and autoimmune diseases
including the immune-deficient "viable motheaten" mouse (40, 41). In view of
these observations and the results discussed above, we suggest that the develop-
ment and persistence of the few Ig-producing B cell clones in scid(Ig') mice may
be in response to chronic stimulation by self antigens and/or opportunistic
microorganisms.
Indication ofT Cells in scid(Ig+)Mice.
￿
That scid(Ig') mice contained functional
T cells in addition to Ig-producing B cells was evident from their ability to reject
allogenic skin grafts, a T cell-dependent process (35). The presence of functional
T cells has been recently confirmed by one of us (A. Carroll) by selectively
growing clones of alloreactive T cells from the spleen of individual scid(Ig')
mice. These clones are IL-2 dependent and show TCR-,Q gene rearrangements
(unpublished results).
About half of the grafted scid(Ig') mice completely rejected their H-2k allo-
grafts (see Table IV). This suggests that many scid(Ig') mice may contain -20-
40 functional T cell precursors, assuming that 1 in every 20 precursors can
recognize a given foreign MHC haplotype (42, 43) and that the progeny of 1-2
precursors is sufficient to mediate allograft rejection. Nonetheless, the T cell
repertoire must be very restricted since half of the grafted scid(Ig') mice failed
to reject (or completely reject) their allografts. Experiments to address the issue
of T cell clonality are currently underway.
Additional evidence for the development of T cells was the high incidence of
T cell lymphomas in scid(Ig') mice. Approximately 40% of 3-9-mo-old scid(Ig')
mice (23 of 58 necropsied mice) had thymic lymphomas. Whether these represent1030
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transformed leaky T cells is not clear, however, because the majority of rear-
ranged TCR-y and TCR-#alleles in such lymphomas are aberrantly rearranged
(17, 19) and most transformants would be expected to lack a functional T cell
receptor. Possibly, most ofthe T cell lymphomas are secondary to the conversion
of scid(Ig) into scid(Ig') mice; i.e., the growth and progression of incipient
lymphomas may be promoted by the leaky Tcells and their products.
Possible Implications of Scid(Ig+) Mice.
￿
Despite the indicated presence of Ig-
producing plasmacytes and alloreactive T cells, most scid(Ig') mice retained the
same general histologic pattern ofsevere lymphocytic deficiency seen in scid(Ig)
mice (5). Splenic cells lacked Ly-5(B220), Ly-1, and surface ', and responded
marginally, if at all, to LPS and Con A. Bone marrow cells lacked detectable
intracellular Fc chains and were unable to generate Ig-producing B cells after
transfer into x-irradiated BALB/c mice. We conclude that the cellular event(s)
responsible for theappearance offunctional lymphocytes inscid(Ig') mice occurs
infrequently and may result in uncontrolled terminal differentiation of the
affected cells because resting lymphocytes, responsive to lymphocyte mitogens
and/or expressing common lymphocyte surface antigens, were not detected.
Two explanations for the appearance of functional lymphocytes in scid(I')
mice can be considered. Both assume that recombination of antigen receptor
genes in scid mice is highly error prone resulting in the premature death of
developing lymphocytes for lack ofa functional antigen receptor. This does not
preclude that the scid mutation could also result in a very low frequency of gene
recombination such that the rate of lymphoid differentiation is severely reduced.
The first explanation postulates that defective scid lymphocytes occasionally
make(bychance) productivegenerearrangementsat two critical antigen receptor
loci (e.g., Hand L chain or TCR-,Q and TCR-a). These rare cells with functional
antigen receptors would presumably arise in all scid mice but remain latent until
activated and clonally expanded as a result ofchance encounter with the appro-
priate naturally occurring antigens. Most of the nonproductive gene re-
arrangements in these functional cells would be expected to consist ofabnormal
J-associated deletions similar to those previously described in transformed scid
lymphocytes (17). The second explanation postulates a low rate ofcell reversion
such that developing scid lymphoid cells occasionally revert to normal in which
case a fraction of the progeny cells go on to make two productive gene re-
arrangements at the appropriate Ig and TCR loci. Genetic reversion at either
scid allele would presumably suffice to normalize a given cell. Lymphocyte
progeny of these reverted cells would be expected to show conventional gene
rearrangements as opposed to rearrangements with aberrant J-associated dele-
tions.
Given either of the above explanations, how does one account for the joint
presence of B and Tcells in scid(Ig') mice? Ifthe cellular events responsible for
scid(Ig') mice were to occur infrequently and independently in early B and T
cells, as required by the first explanation, then one must argue that the devel-
opment of Ig-producing scid B cells is highly dependent on the presence of
functional T cells and that screening for Ig' mice necessarily selects for mice
with both cell types. Conversely, one would also have to argue that T cell
development is dependent on the presence of B cells as there was no clear-cutBOSMA ET AL.
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evidence of functional T cells in scid(Ig) mice (see Table IV). The second
explanation allows that developing scid lymphocytes may revert to normal at any
stageof lymphoid ontogeny; e.g., before or after the commitment of lymphocytes
to the B or T cell pathway. However, the detection of reversion events before
commitment presumably would be favored as this would result in more functional
progeny of both B and T cell types. This assumes that lymphoid stem cells have
bipotentiality.
Clearly, the nature of the cellular event responsible for scid(Ig+) mice remains
to be elucidated. The average number of such events per scid(Ig''') mouse and
the time of their occurrence in lymphoid cell ontogeny will hopefully be resolved
in future experiments with chimeric scid(Ig+) mice containing genotypically
distinct and genetically marked populations of hematopoietic scid cells.
Summary
Although the majority of severe combined immune deficiency (scid) mice lack
functional lymphocytes, some (2-23%) appear to develop a limited number of B
and T cells between 3 and 9 mo old. Most of these leaky scid mice were shown
to contain very few clones (<_3) of Ig-producing plasmacytes. Clonal progeny
were distributed unevenly in the lymphatic tissues and appeared as discrete
plasmacytic foci. In many cases, individual clones persisted for several months
and produced abnormally high concentrations of Ig that included multiple
isotypes. Functional T cells were inferred from the ability of leaky mice to reject
allogeneic skin grafts, a T cell-dependent reaction. Interestingly, ^-40% of leaky
mice developed thymic lymphomas. In other respects, leaky mice resembled
regular scid mice; e.g., their splenic cells failed to express common lymphocyte
antigens (Ly-5[B220], Ly-1) and to proliferate in response to lymphocyte mito-
gens. Histologically, their lymphoid tissues retained the same general pattern of
severe lymphocytic deficiency as scid mice .
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